Lantern Pharma's Series A Round

Lantern Pharma raised a round of funding on May 02, 2017.

Lantern Pharma is advancing precision cancer medicine by combining clinical stage chemotherapeutics with personalized genetic testing to de-risk clinical development.…

Articles about Lantern Pharma's Series A Round: